Related Experiment Video

Updated: Dec 26, 2025

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

9.1K

Multifunctional Protein Conjugates with Built-in Adjuvant (Adjuvant-Protein-Antigen) as Cancer Vaccines Boost Potent

Jing-Jing Du1, Chang-Wei Wang1, Wen-Bo Xu1

  • 1Key Laboratory of Pesticide and Chemical Biology, Ministry of Education, Hubei International Scientific and Technological Cooperation Base of Pesticide and Green Synthesis, International Joint Research Center for Intelligent Bio-sensing Technology and Health, College of Chemistry, Central China Normal University, Wuhan, Hubei 430079, China.

Iscience
|March 9, 2020
PubMed

Insights

This study introduces a novel three-in-one cancer vaccine combining an adjuvant and tumor antigen on a single protein. This innovative approach enhances immune responses against cancer cells, overcoming challenges in traditional cancer vaccine development.

Area of Science:

  • Immunology
  • Biotechnology
  • Oncology

Background:

  • Cancer vaccines often fail due to immune tolerance challenges.
  • Adjuvants are crucial for vaccine efficacy but can cause toxicity.
  • Tumor-associated antigens are key targets for cancer immunotherapy.

Purpose of the Study:

  • To develop a novel "three-in-one" anticancer vaccine construct.
  • To enhance immune responses by integrating adjuvant and antigen.
  • To overcome limitations of traditional cancer vaccine formulations.

Main Methods:

  • Covalent conjugation of a TLR7 agonist (adjuvant) and MUC1 (antigen) to BSA (carrier protein).
  • Creation of self-adjuvanting protein conjugates for enhanced immune stimulation.
  • Evaluation of humoral and cellular immune responses in preclinical models.

Main Results:

  • The three-in-one vaccine significantly increased adjuvant stimulation and reduced systemic toxicities.
  • It facilitated co-delivery of adjuvants and antigens, enhancing immune responses.
  • IgG antibody titers were over 15-fold higher compared to traditional vaccine mixtures.

Conclusions:

  • The novel self-adjuvanting vaccine construct effectively breaks immune tolerance.
  • This approach shows potent antitumor immune responses, suggesting efficacy in personalized immunotherapy.
  • The integrated adjuvant-protein-antigen strategy represents a promising advancement in cancer vaccine development.
Keywords:
BiochemistryConjugateImmunology

More Related Videos

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.6K
Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

2.1K

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
878
Vaccinations01:51

Vaccinations

Overview
50.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
1.2K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
83.1K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.3K